FIELD: medicine.
SUBSTANCE: composition of an aqueous solution of recombinant human interferon alpha-2 contains: recombinant human interferon alpha-2 25.0-200.0 thousand International Units, sodium alginate 10.0-100.0 mg, antioxidant oxidised glutathione 0.006-0.1 mg, the antimicrobial preserving agent Nipagin 0.2-1.8 mg, the stabilising agent Polysorbate 80 (Tween 80) 0.01-1.0 mg, sodium chloride 5.8-7.5 mg, a buffer compound for balancing pH 4.5-7.0 10.0-25.0 mM, water - the rest up to 1 ml.
EFFECT: using the given composition enables creating the aqueous solution of extended release recombinant human interferon alpha-2 for rectal administration.
3 cl, 4 tbl, 2 dwg
Title | Year | Author | Number |
---|---|---|---|
ENCAPSULATED LYPOSOMAL ANTIVIRAL AGENT BASED ON HUMAN INTERFERON ALPHA-2b FOR VAGINAL APPLICATION | 2014 |
|
RU2552851C1 |
HUMAN INTERFERON-ALPHA-TWO AQUEOUS SOLUTION FOR INJECTION | 2002 |
|
RU2238758C2 |
HYPOALLERGENIC MEDICINAL AGENT APPLIED FOR TREATMENT OF INFECTION-INFLAMMATORY DISEASES OF DIFFERENT AETIOLOGY | 2007 |
|
RU2326688C1 |
LIPOSOMAL PERORAL ANTIVIRAL TREATMENT-AND-PROPHYLACTIC AGENT ON BASIS OF HUMAN INTERFERON ALPHA | 2008 |
|
RU2361572C1 |
COMPLEX ACTION MEDICATION AND METHOD OF ITS PRODUCTION | 2012 |
|
RU2519553C1 |
AGENT FOR SEVERE INFECTIOUS DISEASES AND MIXED INFECTIONS | 2008 |
|
RU2366450C1 |
METHOD OF TREATING CHRONIC PROSTATITIS | 2008 |
|
RU2408378C2 |
RECTAL SUPPOSITORY MEDICINAL PRODUCT AND METHOD FOR ITS PREPARATION | 2018 |
|
RU2689320C1 |
RECTAL SUPPOSITORIES AND METHOD FOR PREPARATION THEREOF (OPTIONS) | 2017 |
|
RU2674029C1 |
CURATIVE AGENT | 2005 |
|
RU2283133C1 |
Authors
Dates
2015-10-10—Published
2014-08-28—Filed